• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 88 of 100
Pfizer In Merger Talks With Allergan PLC
Leadership
Pfizer, Allergan Poised for $150 Billion Merger
By Claire GrodenNovember 22, 2015
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
Health
Merck CEO Blasts Company that Raised Drug Prices 5,000%
By Laura LorenzettiNovember 20, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health
AstraZeneca, Sanofi Add New Twist to Pharma Merger Mania
By Reuters and Fortune EditorsNovember 20, 2015
MSMB Capital Management CIO Martin Shkreli
Finance
Turing CEO Invested in This Penny Stock Biotech to Keep It Alive
By Laura LorenzettiNovember 19, 2015
Pfizer And AstraZeneca's Billion Dollar Battle
Leadership
A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By Alan MurrayNovember 19, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership
The Treasury Will Crack Down on ‘Tax Inversions’ This Week
By Geoffrey SmithNovember 19, 2015
571977919
Health
Global Drug Spending Will Reach $1.4 Trillion by 2020
By Laura LorenzettiNovember 18, 2015
Police Operation in Saint Denis
Tech
Paris Siege and Square Prices IPO–5 Things to Know Today
By Laura Lorenzetti and Geoffrey SmithNovember 18, 2015
Flibanserin
Health
Why ‘Female Viagra’ Is Not Selling
By Robert HackettNovember 17, 2015
14th Annual Elton John AIDS Foundation An Enduring Vision Benefit - Show
Finance
Why Mylan Just Lost The Largest Hostile Takeover Battle Ever
By Jen WiecznerNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership
Mylan, Valeant and Theranos: What the Heck, Biotech?
By Jeffrey SonnenfeldNovember 13, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health
Mylan’s Hostile Bid for Perrigo Fails
By ReutersNovember 13, 2015
Bill Ackman
Health
Valeant, Ackman Must Face U.S. Insider Trading Lawsuit
By ReutersNovember 11, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant CEO Defends Firm but Says He Doesn’t Have ‘Full Knowledge’
By Stephen GandelNovember 10, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health
Astrazeneca is Buying ZS Pharma for $2.7 billion
By Laura LorenzettiNovember 6, 2015
1...
  • 86
  • 87
  • 88
  • 89
  • 90
...100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.